首页> 外文期刊>Current medical research and opinion >Levodopa-related wearing-off in Parkinson's disease: identification and management.
【24h】

Levodopa-related wearing-off in Parkinson's disease: identification and management.

机译:帕金森氏病中左旋多巴相关的衰老:识别和管理。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Levodopa is currently the most effective treatment for Parkinson's disease (PD); however, long-term levodopa therapy often results in motor complications, such as motor fluctuations and dyskinesia. The initial complication is commonly wearing-off, which is the re-emergence of motor and non-motor symptoms before the next scheduled levodopa dose. OBJECTIVE: The purpose of this article was to review published literature that discusses wearing-off, focusing on the role of the healthcare professional, including the primary care physician, in the effective management of wearing-off. METHODS: An electronic literature search was conducted using MEDLINE and EMBASE to find articles discussing wearing-off and its management using the following keywords: 'Parkinson's disease'; 'wearing-off'; 'levodopa'; 'primary care'. FINDINGS AND CONCLUSIONS: Current evidence indicates that a consistent delivery of levodopa should improve long-term symptomatic efficacy and may prevent or delay motor complications. A number of therapeutic options are available to optimize therapeutic outcome, including modification of the levodopa dose or dosing schedule,switching to another levodopa formulation and the use of adjunct therapies, such as catechol-O-methyl transferase inhibitors, dopamine agonists and monoamine oxidase-B inhibitors. The management of wearing-off is dependent upon the early identification of symptoms and the initiation of effective treatment. Key issues are the need to educate patients and to facilitate good communication with both primary and secondary healthcare professionals. In most cases, patients with PD initially present to primary healthcare professionals who may refer the patient to a neurologist once disease management becomes more complex. However, in many cases, especially in rural areas where neurologists may not be widely available, the primary healthcare professionals may manage the patient throughout the disease course. Limitations of this review include the restricted search criteria and selected search period.
机译:背景:左旋多巴目前是治疗帕金森氏病(PD)的最有效方法。然而,长期左旋多巴疗法通常会导致运动并发症,例如运动波动和运动障碍。最初的并发症通常是疲倦的,这是在下一次计划的左旋多巴剂量之前运动和非运动症状的再次出现。目的:本文的目的是回顾有关磨损的已发表文献,重点是包括初级保健医生在内的医疗专业人员在磨损的有效管理中的作用。方法:使用MEDLINE和EMBASE进行电子文献搜索,以查找讨论磨损及其管理的文章,关键词如下:“帕金森氏病”; '报废;严重磨损'; '左旋多巴'; '初级卫生保健'。结论和结论:目前的证据表明,左旋多巴的持续给药应改善长期症状疗效,并可以预防或延迟运动并发症。有多种治疗选择可用于优化治疗效果,包括调整左旋多巴的剂量或给药方案,改用另一种左旋多巴制剂以及使用辅助疗法,例如儿茶酚-O-甲基转移酶抑制剂,多巴胺激动剂和单胺氧化酶- B抑制剂。磨损的处理取决于症状的早期识别和有效治疗的开始。关键问题是需要教育患者并促进与初级和二级医疗保健专业人员的良好沟通。在大多数情况下,PD患者最初会出现在初级保健专业人员那里,一旦疾病管理变得更加复杂,他们可能会将患者转介给神经科医生。但是,在许多情况下,尤其是在神经科医生可能不广泛使用的农村地区,初级保健专业人员可以在整个疾病过程中对患者进行管理。该评论的局限性包括受限的搜索条件和选择的搜索时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号